PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
BBIO
Ticker

BBIO

Congressional Trades
10
by 1 members
Buys
10
100%
Sells
0
0%
Total Volume
$80K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats10 · 100%
Republicans0 · 0%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
2
Aug '25
2
Sep '25
6
Mar '26
Democrats100Net buyers
vs
Republicans00Neutral
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$420K
    BRIDGEBIO PHARMA INC.
    H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
  • 2026-04-17$60K
    BRIDGEBIO PHARMA
    Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.
  • 2026-01-20$270K
    BRIDGEBIO PHARMA INC.
    Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
  • 2026-01-16$60K
    BRIDGEBIO PHARMA
    Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.
  • 2025-10-20$270K
    BRIDGEBIO PHARMA INC.
    Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act PBM Reform Act - H.R. 4317 ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
  • 2025-10-20$60K
    BRIDGEBIO PHARMA
    Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.
  • 2025-10-11$20K
    BRIDGEBIO PHARMA
    PBM Policy Reform. Prior authorization. Utilization management.
  • 2025-07-30$20K
    BRIDGEBIO PHARMA
    PBM Policy Reform. Prior authorization. Utilization management.
  • 2025-07-21$20K
    BRIDGEBIO PHARMA
    Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.
  • 2025-07-21$0
    BRIDGEBIO PHARMA
    PBM Policy Reform. Prior authorization. Utilization management.

Congressional Momentum

buy vs. sell pressureACCUMULATING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
100
6 buys6 total0 sells
$48K buys · $0 sells
All-Time
100
10 buys10 total0 sells
$80K buys · $0 sells
Cumulative Net Position (buy vol − sell vol)
+$80K
2025-0810 trades plotted2026-03

Trade Activity Timeline

Congressional buys & sells by month · last 3 months w/ activity

25/08
25/09
26/03
BuysSellsOtherHigh-volume month

All Disclosed Trades

DateMemberActionAmountFiling Delay
2026-03-19DGilbert CisnerosBUY$1K – $15K20d
2026-03-18DGilbert CisnerosBUY$1K – $15K21d
2026-03-03DGilbert CisnerosBUY$1K – $15K36d
2026-03-19DGilbert CisnerosBUY$1K – $15K19d
2026-03-18DGilbert CisnerosBUY$1K – $15K20d
2026-03-03DGilbert CisnerosBUY$1K – $15K35d
2025-09-22DGilbert CisnerosBUY$1K – $15K21d
2025-09-22DGilbert CisnerosBUY$1K – $15K18d
2025-08-08DGilbert CisnerosBUY$1K – $15K38d
2025-08-08DGilbert CisnerosBUY$1K – $15K35d